RxDoctor Payments Data

John Kilgore, MD

Adult Reconstructive Orthopaedic Surgery · Clearwater, FLNPI 1770526410

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $96,000 of the $110,989 with a category attached, or 86.5%. Stryker accounts for 99.7% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $44,427 and has fallen 99.7% since, to $119 in 2025.

$110,989in general payments, 2019–2025

Across 148 payments — averaging $749.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$111K
  • Amgen$209
  • Johnson & Johnson$65
  • Molnlycke Health Care US, LLC$38
  • Theragen, Inc.$23
  • Pacira Therapeutics, Inc.$18

What the payments were for

  • Consulting fees$96,00086%
  • Travel & lodging$12,26711%
  • Food & beverage$2,7232%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker140$110,637
Amgen2$209
Johnson & Johnson2$65
Molnlycke Health Care US, LLC2$38
Theragen, Inc.1$23
Pacira Therapeutics, Inc.1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$110,989 in reported general payments places this provider in the 85th percentile of 96 adult reconstructive orthopaedic surgery providers in Florida.

See all adult reconstructive orthopaedic surgery providers in Florida

Medicare billing

Part B allowed, 2024
$399,575
Medicare patients
554
Services billed
4,847

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib179$8,522
Meloxicam53$226
Tizanidine Hcl21$129
Mupirocin25$129
Amoxicillin50$101
Methylprednisolone15$80

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Clearwater

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →